Literature DB >> 16422789

Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause.

Lorraine Dennerstein1, Richard D Hayes.   

Abstract

INTRODUCTION: Despite rapid current and anticipated growth in the number of women who will spend a substantial portion of their life span in the postmenopausal period, the nature, incidence, and prevalence of changes in sexual function during and after the menopausal transition remain poorly characterized. AIM: Challenges inherent in studying the menopausal transition and proposed additions and changes that have emerged from recent consensus conferences on female sexual dysfunction are reviewed.
METHODS: Specific topics related to female sexual dysfunction were presented in a Postmenopausal FSD Roundtable in which multidisciplinary international experts participated. MAIN OUTCOME MEASURE: Expert opinion was based on a review of evidence-based medical literature, presentation, and internal discussion.
RESULTS: Knowledge concerning sexual function in the menopause is limited, in part, due to the difficulty in designing and conducting studies that adequately address these changes over time, and which also permit the effects of menopause to be distinguished from more general changes associated with aging. Moreover, the study of female sexual function and dysfunction is in the midst of significant transition: a tentative definition of the stages of reproductive aging and menopause has recently been advanced, and a set of comprehensive changes to the diagnostic framework that defines female sexual dysfunction is under review.
CONCLUSIONS: In spite of fast-moving changes in this field of study, it is possible to reach some tentative conclusions about how women's sexual function changes after menopause: postmenopausal women report a relatively high rate of sexual dysfunction (higher than men). There is a marked decline in sexual interest and frequency of sexual activity. This decline can be ameliorated by a number of psychosocial factors, although vaginal dryness and dyspareunia seem to be driven primarily by declining estradiol. The effects of menopause appear to be incremental and additional to those characteristic of aging.

Entities:  

Mesh:

Year:  2005        PMID: 16422789     DOI: 10.1111/j.1743-6109.2005.00128.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  12 in total

1.  Cues resulting in desire for sexual activity in women.

Authors:  Katie McCall; Cindy Meston
Journal:  J Sex Med       Date:  2006-09       Impact factor: 3.802

2.  Effects of nutraceuticals on quality of life and sexual function of perimenopausal women.

Authors:  S Caruso; S Cianci; M Cariola; V Fava; A M C Rapisarda; A Cianci
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

3.  Dyspareunia in Puerto Rican middle-aged women.

Authors:  Yaniris R Avellanet; Ana Patricia Ortiz; José R Pando; Josefina Romaguera
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

Review 4.  Female sexual dysfunction.

Authors:  Erdogan Aslan; Michelle Fynes
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-01

5.  Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study.

Authors:  Jennifer S McCall-Hosenfeld; Sarah A Jaramillo; Claudine Legault; Karen M Freund; Barbara B Cochrane; Joann E Manson; Nanette K Wenger; Charles B Eaton; Beatriz L Rodriguez; S Gene McNeeley; Denise Bonds
Journal:  J Gen Intern Med       Date:  2008-10-07       Impact factor: 5.128

6.  Using ecological momentary assessment to investigate short-term variations in sexual functioning in a sample of peri-menopausal women from Iran.

Authors:  Amir H Pakpour; Mir Saeed Yekaninejad; Gianandrea Pallich; Andrea Burri
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  FEMALE SEXUAL DYSFUNCTION (FSD) IN WOMEN HEALTH CARE WORKERS.

Authors:  Konstantinos Stamatiou; Maria Margariti; Eftichia Nousi; Dimitra Mistrioti; Richard Lacroix; Maria Saridi
Journal:  Mater Sociomed       Date:  2016-06-01

8.  Sexuality in midlife: Where the passion goes?

Authors:  Navneet Magon; Monica Chauhan; Sonia Malik; Duru Shah
Journal:  J Midlife Health       Date:  2012-07

9.  Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.

Authors:  David J Portman; Andrew M Kaunitz; Kazem Kazempour; Hana Mekonnen; Sailaja Bhaskar; Joel Lippman
Journal:  Menopause       Date:  2014-10       Impact factor: 2.953

10.  BIOPSYCHOSOCIAL DETERMINANTS OF HYPOACTIVE SEXUAL DESIRE IN WOMEN: A NARRATIVE REVIEW.

Authors:  Mina Malary; Soghra Khani; Mehdi Pourasghar; Mahmood Moosazadeh; Zeinab Hamzehgardeshi
Journal:  Mater Sociomed       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.